Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: Hexylaminolevulinate and Aminolevulinic Acid Nano Emulsion Versus Methylaminolevulinate

NCT02367547 is registered in ClinicalTrials.gov with Joint Authority for Päijät-Häme Social and Health Care as lead sponsor.

NCT NCT02367547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02367547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: Hexylaminolevulinate and Aminolevulinic Acid Nano Emulsion Versus Methylaminolevulinate
Lead sponsor
Joint Authority for Päijät-Häme Social and Health Care
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2015
Completion date
December 31, 2025
Enrollment
117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, basal cell, neoplasms, basal cell, photochemotherapy, photosensitizing agents